Are Analysts Expecting A Better 2020 For Coherus Biosciences Inc (CHRS)?

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $1.50, with 3.83 million shares of worth about $5.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.73% during that period and on December 12, 2024 the price saw a […]

These Numbers Could Change Investor Views For Coherus Biosciences Inc (NASDAQ: CHRS)

Currently, there are 115.21M common shares owned by the public and among those 110.58M shares have been available to trade. The company’s stock has a 5-day price change of 41.32% and 30.53% over the past three months. CHRS shares are trading -48.65% year to date (YTD), with the 12-month market performance down to -25.65% lower. […]

Coherus Biosciences Inc (NASDAQ: CHRS) Has Another Chance To Impress You

Currently, there are 112.22M common shares owned by the public and among those 110.58M shares have been available to trade. The company’s stock has a 5-day price change of 55.81% and -5.88% over the past three months. CHRS shares are trading -61.56% year to date (YTD), with the 12-month market performance down to -34.02% lower. […]

Coherus Biosciences Inc (NASDAQ: CHRS) Not A Good Play Anymore?

Coherus Biosciences Inc (CHRS) concluded trading on Wednesday at a closing price of $1.10, with 8.82 million shares of worth about $9.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -47.87% during that period and on November 20, 2024 the price saw a […]

Coherus Biosciences Inc (NASDAQ: CHRS) – Not A Clear Buying Opportunity?

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.82, with 9.45 million shares of worth about $7.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.32% during that period and on November 07, 2024 the price saw a […]

Is There More Upside Ahead For Coherus Biosciences Inc (NASDAQ: CHRS)

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.85, with 3.23 million shares of worth about $2.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.59% during that period and on October 17, 2024 the price saw a […]

Tomorrow Is Not Likely To Be Same For Coherus Biosciences Inc (CHRS)

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.97, with 3.07 million shares of worth about $2.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.73% during that period and on October 10, 2024 the price saw a […]

Set Your Sights On Coherus Biosciences Inc (NASDAQ: CHRS)’S Upside Potential

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $1.04, with 15.36 million shares of worth about $15.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -55.36% during that period and on October 03, 2024 the price saw a […]

Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?

Currently, there are 111.36M common shares owned by the public and among those 106.20M shares have been available to trade. Insiders at the company have transacted a total of 3 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]

Is Coherus Biosciences Inc (NASDAQ: CHRS) Proving The Doubters Wrong?

Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $2.09, with 3.42 million shares of worth about $7.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -51.84% during that period and on Thursday, February 01 price saw a loss […]